The World Health Organization has declared Hepatitis D as cancer-causing. This announcement coincides with World Hepatitis ...

This story is part of a larger series on viroids and virusoids, small infectious RNAs. It is also the seventh installment in a series on hepatitis D virus, a virusoid-like pathogen that causes serious ...

This story is part of a larger series on viroids and virusoids, small infectious RNAs. It is also the fifth installment in a series on hepatitis D virus, a virusoid-like pathogen that causes serious ...

Please provide your email address to receive an email when new articles are posted on . Patients with HIV and hepatitis B coinfection are at an increased risk for hepatitis D. Patients with hepatitis ...

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in ...

This large-scale exploratory study demonstrated that the prevalence of HDV antibody positivity was very low (0.24%) in Chinese patients with chronic HBV infection, with only one of the 4,936 patients ...

A new review published on JAMA Network discusses the magnitude of the current hepatitis D virus (HDV) epidemic and its implications for public health. HDV is a small ribonucleic acid (RNA) virus that ...

Treatment with the investigational drug bulevirtide plus pegylated interferon alfa-2a (PegIFNα) resulted in more patients achieving undetectable levels of hepatitis D virus (HDV) RNA compared with ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Up to 57% of patients with chronic hepatitis D virus ...

The world's first prescription for a groundbreaking monoclonal antibody treatment for the hepatitis D virus has been issued ...